Several evidences show that NAFLD development is associated with the amount of visceral fat, AST, ALT, total cholesterol, triglycerides, serum insulin and insulin resistance, which is assessed by the HOMA-IR. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.